Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
Police say violent crime improving in downtown Raleigh, but more work is needed
Recommended
UNC has a new chancellor. Why interim Lee Roberts got the permanent job.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Fsd Pharma Inc Cl B
(NQ:
HUGE
)
0.0899
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Fsd Pharma Inc Cl B
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
BioMedNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Incorporates New Subsidiary to Capitalize on Drug Development Incentives in Australia
January 09, 2023
Via
Investor Brand Network
FSD Pharma Inc Incorporates New Subsidiary to Capitalize on Drug Development Incentives in Australia
January 09, 2023
From
FSD Pharma Inc.
Via
Business Wire
PsychedelicNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) to Participate in Upcoming J.P. Morgan Healthcare Conference
January 06, 2023
Via
Investor Brand Network
FSD Pharma to Attend 41st Annual J.P. Morgan Healthcare Conference 2023
January 06, 2023
From
FSD Pharma Inc.
Via
Business Wire
PsychedelicNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9A) Announces Changes to the Board of Directors
November 30, 2022
Via
Investor Brand Network
FSD Pharma Announces Changes to the Board of Directors
November 28, 2022
From
FSD Pharma Inc.
Via
Business Wire
InvestorNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Reports Multimillion-Dollar Claim Has Been Dismissed
November 15, 2022
Via
Investor Brand Network
InvestorNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9A) Announces Dismissal of Claim by Former CEO
November 10, 2022
Via
Investor Brand Network
FSD Pharma Announces Arbitrator Dismisses Claims by Former CEO, Dr. Raza Bokhari
November 10, 2022
From
FSD Pharma Inc.
Via
Business Wire
FSD Pharma Inc. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
September 29, 2022
From
FSD Pharma Inc.
Via
Business Wire
BioMedNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9A) Announces Participation at H.C. Wainwright 24th Annual Global Investment Conference
September 12, 2022
Via
Investor Brand Network
BioMedNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9A) Secures FDA and Health Canada Approval for Phase 2 Trial of FSD201
September 06, 2022
Via
Investor Brand Network
Exposures
Product Safety
FSD Pharma Participating in H.C. Wainwright 24th Annual Global Investment Conference, On-Demand Presentation Available
September 12, 2022
From
FSD Pharma Inc.
Via
Business Wire
FDA and Health Canada Clear IND for FSD Pharma to Proceed with Phase 2 Trial of FSD201 for Nociplastic Pain Associated with Idiopathic Mast Cell Activation Syndrome
September 06, 2022
From
FSD Pharma Inc.
Via
Business Wire
PsychedelicNewsBreaks – FSD Pharma Inc.’s (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9A) Lucid Psycheceuticals Files for Patent on Novel Formulations of Palmitoylethanolamide
July 13, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent On Novel Formulations of Palmitoylethanolamide, Presents Preclinical Toxicology Results at an International Symposium
July 13, 2022
From
FSD Pharma Inc.
Via
Business Wire
BioMedNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Releases Report of Annual General Meeting of Shareholders
June 27, 2022
Via
Investor Brand Network
FSD Pharma Inc. Announces Results of Annual General Meeting of Shareholders And Other Corporate Updates
June 27, 2022
From
FSD Pharma Inc.
Via
Business Wire
BioMedNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Submits IND Application
June 01, 2022
Via
Investor Brand Network
Topics
Cannabis
Exposures
Cannabis
Product Safety
Stocks That Hit 52-Week Lows On Friday
June 24, 2022
On Friday, 61 companies hit new 52-week lows.
Via
Benzinga
BioMedNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9A) Files IND Application for Phase-2 Trial of FSD-PEA
May 31, 2022
Via
Investor Brand Network
Exposures
Product Safety
FSD Pharma Files Investigational New Drug Application (“IND”) with FDA and Health Canada for Phase-2 Trial of FSD-201 for an Inflammatory disorder and Provides Corporate Updates
May 31, 2022
From
FSD Pharma Inc.
Via
Business Wire
BioMedNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9A) Announces Issuance of Circular, Incentive Plan and Granting of PSUs
May 24, 2022
Via
Investor Brand Network
FSD Pharma Issues Circular, Adopts Incentive Plan and Grants PSUs
May 24, 2022
From
FSD Pharma Inc.
Via
Business Wire
PsychedelicNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9A) Featured in InvestmentPitch Media Video
May 11, 2022
Via
Investor Brand Network
PsychedelicNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Closes CAD$16.4M Sale of Non-Core Assets
May 10, 2022
Via
Investor Brand Network
Topics
Cannabis
Exposures
Cannabis
FSD Pharma Closes CA$16.4M Sale Of Ontario Cannabis Processing Facility, Here's What's Next
May 10, 2022
FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRE: 0K9A) has closed the sale of the company’s former cannabis processing facility located in Cobourg, Ontario, Canada, for gross proceeds of CA$16.4...
Via
Benzinga
FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets
May 10, 2022
From
FSD Pharma Inc.
Via
Business Wire
FSD Pharma Announces Dismissal of Derivative Complaint
May 06, 2022
From
FSD Pharma Inc.
Via
Business Wire
Psyched: Elon Musk Praises Psychedelics Over Antidepressants, Field Trip To Split In Two, Colorado MDMA Bill Moves Forward
May 02, 2022
The world’s richest man gave another public nod to psychedelics medicine in favor of traditional mental health solutions.
Via
Benzinga
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.